Key Takeaways
- • Nestlé divests its mainstream vitamins, minerals, and supplements (VMS) business to U.S.-based Yellow Wood Partners for $1 billion, marking a significant portfolio rationalization in the nutritional products segment.
- • The transaction encompasses seven established brands—Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride, and Sisu—plus the U.S. private-label supplements business, representing a material exit from the mainstream consumer supplements market.
- • The deal reflects Nestlé's strategic portfolio review and repositioning away from mass-market VMS products, likely signaling a shift in resource allocation toward higher-margin or specialty nutrition segments within its broader health science operations.
Summary
Nestlé announced on September 1, 2026, that it has agreed to divest its mainstream vitamins, minerals, and supplements business to Yellow Wood Partners, a U.S.-based investment firm, in a transaction valued at $1 billion. The divestment represents a strategic exit from a core consumer health category and reflects the company's ongoing portfolio optimization efforts.
The transaction includes seven major brands: Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride, and Sisu, alongside Nestlé's U.S. private-label supplements operations. This scope indicates a comprehensive transfer of mainstream VMS assets rather than a selective brand sale, underscoring the company's intention to substantially reduce its presence in the mass-market supplements segment.
The $1 billion valuation provides clarity on Nestlé's assessment of the mainstream supplements business unit. While the transaction price reflects the portfolio's market value, the deal's strategic significance lies in Nestlé's apparent reallocation of capital and management focus. The divestment aligns with a broader strategic review that has positioned Nestlé's Health Science division for a more focused portfolio, potentially concentrating resources on higher-value-added nutrition categories and specialty segments rather than competing in the commoditized mainstream VMS market.
Yellow Wood Partners' acquisition of this diversified brand portfolio and private-label business positions the investment firm as a significant player in the North American supplements market. The transaction is expected to close following customary regulatory approvals and closing conditions typical of deals of this magnitude and scope.
The transaction includes seven major brands: Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride, and Sisu, alongside Nestlé's U.S. private-label supplements operations. This scope indicates a comprehensive transfer of mainstream VMS assets rather than a selective brand sale, underscoring the company's intention to substantially reduce its presence in the mass-market supplements segment.
The $1 billion valuation provides clarity on Nestlé's assessment of the mainstream supplements business unit. While the transaction price reflects the portfolio's market value, the deal's strategic significance lies in Nestlé's apparent reallocation of capital and management focus. The divestment aligns with a broader strategic review that has positioned Nestlé's Health Science division for a more focused portfolio, potentially concentrating resources on higher-value-added nutrition categories and specialty segments rather than competing in the commoditized mainstream VMS market.
Yellow Wood Partners' acquisition of this diversified brand portfolio and private-label business positions the investment firm as a significant player in the North American supplements market. The transaction is expected to close following customary regulatory approvals and closing conditions typical of deals of this magnitude and scope.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.